Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis

Abstract: Secondary acute myeloid leukemia (s-AML) includes therapy-related AML and AML evolving from antecedent hematological disorder (AHD). s-AML arising after treating AHD likely represents a prognostically distinct, high-risk disease category. In this study, treated s-AML (ts-AML) was defined b...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Prajwal Boddu, Hagop M. Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi, Srdan Verstovsek, Elias Jabbour, Gautam Borthakur, Marina Konopleva, Kapil N. Bhalla, Naval Daver, Courtney D. DiNardo, Christopher B. Benton, Koichi Takahashi, Zeev Estrov, Sherry R. Pierce, Michael Andreeff, Jorge E. Cortes, Tapan M. Kadia
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2017-07-01
Schriftenreihe:	Blood Advances
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2473952920302500
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!